Skip to main content

Gout: Serum Urate Target (Recommended for eMeasure Trial Approval)

CBE ID
2549e
1.4 Project
Musculoskeletal Endorsement Maintenance
Endorsement Status
Approved for Trial Use
1.1 New or Maintenance
Maintenance
Previous Endorsement Cycle
Spring 2014
Is Under Review
No
1.3 Measure Description

Percentage of patients aged 18 and older with a diagnosis of gout treated with urate-lowering therapy (ULT) for at least 12 months, whose most recent serum urate result is less than 6.8 mg/dL.

    • 1.14 Numerator

      Patients whose most recent serum urate level is less than 6.8 mg/dL

    • 1.15 Denominator

      Adult patients aged 18 and older with a diagnosis of gout treated with urate lowering therapy (ULT) for at least 12 months

    • Exclusions

      Patients with a history of solid organ transplant

    • Most Recent Endorsement Activity
      Approved for Trial Use Musculoskeletal Endorsement Maintenance Project
      Initial Endorsement
      Last Updated
    • Steward
      American College of Rheumatology
      Steward Organization POC Email
      [email protected]
      Steward Organization Copyright

      N/A - measure is still being tested